Discontinuation report NORPROLAC
| Report ID | 135529 |
| Drug Identification Number | 02223775 |
| Brand name | NORPROLAC |
| Common or Proper name | quinagolide hydrochloride |
| Company Name | FERRING INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | QUINAGOLIDE |
| Strength(s) | 0.15MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | Blister packs of 30 tablets |
| ATC code | G02CB |
| ATC description | OTHER GYNECOLOGICALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2021-05-30 |
| Actual discontinuation date | 2021-06-02 |
| Remaining supply date | 2021-05-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | For patients, please discuss alternative treatment options with your health care professional. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 200 YORKLAND BLVD TORONTO, ONTARIO CANADA M2J 5C1 |
| Company contact information | 1-800-263-4057 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2021-06-03 | English | Compare |
| v8 | 2021-06-02 | French | Compare |
| v7 | 2021-06-02 | English | Compare |
| v6 | 2021-04-29 | French | Compare |
| v5 | 2021-04-29 | English | Compare |
| v4 | 2021-03-30 | French | Compare |
| v3 | 2021-03-30 | English | Compare |
| v2 | 2021-03-11 | French | Compare |
| v1 | 2021-03-11 | English | Compare |
Showing 1 to 9 of 9